Statement of Changes in Beneficial Ownership (4)
December 12 2014 - 5:48PM
Edgar (US Regulatory)
LIMITED POWER OF ATTORNEY - SECURITIES LAW COMPLIANCE
The undersigned, as an Officer of Neurocrine Biosciences, Inc. (the "Corporation"),
hereby constitutes and appoints, jointly and severally Kevin C. Gorman and Darin Lippoldt, each
of them, the undersigned's true and lawful attorney-in-fact and agent, each with the power of
substitution for her in any and all capacities to complete and execute such Forms 144, advisable
pursuant to Rule 144 promulgated under the Securities Act of 1933 (as amended) and Forms 3, 4,
and 5 advisable pursuant to section 16 of the Securities Exchange Act of 1934, and other forms
as such attorney shall in his or her discretion determine to be required by the rules and
regulations promulgated thereunder, or any successor laws and regulations, as a consequence of
the undersigned's ownership, acquisition or disposition of securities of the Corporation, and to
do all acts necessary in order to file such forms with the Securities and Exchange Commission,
any securities exchange or national association, the Corporation and such other person or agency
as the attorney shall deem appropriate. The undersigned hereby ratifies and confirms all that said
attorneys-in-fact and agents shall do or cause to be done by virtue hereof.
This Limited Power of Attorney is executed at San Diego, California, as of the date set
forth below.
__________________________________
(Signature) Timothy P. Coughlin
Date: 12/4/14
Neurocrine Biosciences (NASDAQ:NBIX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Neurocrine Biosciences (NASDAQ:NBIX)
Historical Stock Chart
From Apr 2023 to Apr 2024